Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Related Citations for PubMed (Select 22635217)

1.

Secondary prevention in thrombotic antiphospholipid syndrome.

Pengo V, Denas G, Banzato A, Bison E, Bracco A, Facchinetti M, Hoxha A, Ruffatti A.

Lupus. 2012 Jun;21(7):734-5. doi: 10.1177/0961203312444773. Review.

PMID:
22635217
2.

Antiphospholipid antibody syndrome.

Lim W.

Hematology Am Soc Hematol Educ Program. 2009:233-9. doi: 10.1182/asheducation-2009.1.233. Review.

3.

Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?

Cohen H, Machin SJ.

Lupus. 2010 Apr;19(4):486-91. doi: 10.1177/0961203310361355. Review.

PMID:
20353992
4.

Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis.

Meroni PL, Moia M, Derksen RH, Tincani A, McIntyre JA, Arnout JM, Koike T, Piette JC, Khamashta MA, Shoenfeld Y.

Lupus. 2003;12(7):504-7. Review.

PMID:
12892388
5.
6.

Antiphospholipid antibodies in critical illness.

Dentali F, Crowther M.

Crit Care Med. 2010 Feb;38(2 Suppl):S51-6. doi: 10.1097/CCM.0b013e3181c9e363. Review.

PMID:
20083914
7.

[The management of thrombosis in the antiphospholipid antibody syndrome: insights from recent clinical trials and remaining unsolved issues].

Wahl D, Perret-Guillaume C, Piette JC.

Rev Med Interne. 2008 Sep;29(9):731-4. doi: 10.1016/j.revmed.2008.05.013. Epub 2008 Jun 26. French.

PMID:
18584919
8.

Intensity and duration of anticoagulation therapy in antiphospholipid syndrome.

Les I, Ruiz-Irastorza G, Khamashta MA.

Semin Thromb Hemost. 2012 Jun;38(4):339-47. doi: 10.1055/s-0032-1304720. Epub 2012 Mar 30. Review.

PMID:
22467528
9.

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T.

J Thromb Haemost. 2005 May;3(5):848-53.

PMID:
15869575
10.

High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'.

Pengo V, Ruiz-Irastorza G, Denas G, Andreoli L, Khamashta M, Tincani A.

Autoimmun Rev. 2012 Jun;11(8):577-80. doi: 10.1016/j.autrev.2011.10.016. Epub 2011 Oct 22. Review.

PMID:
22036827
11.

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.

Ruiz-Irastorza G, Hunt BJ, Khamashta MA.

Arthritis Rheum. 2007 Dec 15;57(8):1487-95. Review.

12.

[Management of antiphospholipid syndrome].

Saadoun D, Piette JC, Wahl D, Costedoat-Chalumeau N.

Rev Med Interne. 2012 Apr;33(4):217-22. doi: 10.1016/j.revmed.2012.01.007. Epub 2012 Feb 21. Review. French.

PMID:
22360832
13.

Which patients with unprovoked VTE should receive extended anticoagulation? the minority.

Donadini MP, Ageno W.

J Thromb Thrombolysis. 2011 Apr;31(3):301-5. doi: 10.1007/s11239-011-0565-x. Review.

PMID:
21327508
15.

Intensity of warfarin coagulation in the antiphospholipid syndrome.

Crowther M, Crowther MA.

Curr Rheumatol Rep. 2010 Feb;12(1):64-9. doi: 10.1007/s11926-009-0070-9. Review.

PMID:
20425536
16.
17.

[The optimal duration of anticoagulant treatment following pulmonary embolism].

Couturaud F.

Rev Mal Respir. 2011 Dec;28(10):1265-77. doi: 10.1016/j.rmr.2011.04.017. Epub 2011 Nov 3. Review. French.

PMID:
22152935
18.

Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.

Brunner HI, Chan WS, Ginsberg JS, Feldman BM.

J Rheumatol. 2002 Mar;29(3):490-501.

PMID:
11908562
19.

Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.

Dager WE.

Ann Pharmacother. 2012 Jan;46(1):79-88. doi: 10.1345/aph.1P626. Epub 2011 Dec 27. Review.

PMID:
22202495
20.

[Therapy and secondary prevention of venous thromboembolism with vitamin K antagonists].

Bauersachs RM.

Internist (Berl). 2003 Dec;44(12):1491-9. Review. German.

PMID:
14689191
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk